Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) ...

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...

"The last thing he said before passing was, 'I should have finished the job of drowning her and burning down the house.'" ...

KU has nominated four juniors for a prestigious scholarship that recognizes their academic excellence and undergraduate ...

LMH and the KU Health System have entered into an agreement with Emporia hospital Newman Regional Health, the organizations ...

Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood cancers undergoing treatment.

Lung metastases are a devastating reality for over half of cancer patients whose tumors spread beyond their initial sites. These secondary lung tumors develop in part because of unique conditions ...

Ear cancer is when abnormal cells in the ear start to grow and divide in an uncontrolled way. Most of these cancers start in the skin of the outer ear. Cancers that develop inside the ear, known as ...

Pharmaceutical company GSK and Oxford University are teaming up to devise a groundbreaking cancer vaccine poised to stop the disease from developing in the first place. The ambition lies in ...